Resultados de la búsqueda 291-300 of 17425 for B cell lymphomas
... B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. ... lymphoma (B-LLy) when treated with ALL therapy without inotuzumab ozogamicin. ... lymphoma (B ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma.
Jacksonville, Fla. The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies ...
... cell lymphoma that has come back or does not respond to treatment. ... A virus, called VSV-hIFNbeta-NIS, which has been changed in a certain way, may be able to ...
Advanced diagnosis and treatment. Mayo Clinic doctors use the latest laboratory technology and techniques to study your cancer cells to make a correct diagnosis ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Testing the Addition of an Anti-cancer ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. International Registry for Men With ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?